19.53

1.77% 0.34

After Hours: 19.55 0.02 +0.10%

Rigel Pharmaceuticals (RIGL)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Rigel Pharmaceuticals stock is traded at $19.53, with a volume of 122.63K. It is up +1.77% in the last 24 hours and down -0.20% over the past month. Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

Previous Close:

$19.19

Open:

$19.37

24h Volume:

122.63K

Relative Volume:

0.55

Market Cap:

$349.00M

Revenue:

$116.88M

Net Income/Loss:

$-25.09M

P/E Ratio:

-139.50

EPS:

-0.14

Net Cash Flow:

$-20.74M

1W Performance:

-1.01%

1M Performance:

-0.20%

6M Performance:

-29.26%

1Y Performance:

+112.88%

1-Day Range:

$19.02

$19.71

1-Week Range:

$18.32

$19.91

52-Week Range:

$7.4843

$29.82

Rigel Pharmaceuticals Stock (RIGL) Company Profile

Name

Rigel Pharmaceuticals

Sector

Healthcare (1177)

Industry

Biotechnology (671)

Phone

650-624-1100

Address

611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA

Employee

164

Twitter

@rigelpharma

Next Earnings Date

2024-11-07

Latest SEC Filings

RIGL's Discussions on Twitter

Compare RIGL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RIGL Rigel Pharmaceuticals	19.53	352.62M	116.88M	-25.09M	-20.74M	-0.14
ONC Beone Medicines Ltd Adr	246.68	25.81B	3.81B	-644.79M	-669.77M	-6.24
VRTX Vertex Pharmaceuticals Inc	447.09	111.46B	11.10B	-988.90M	-1.26B	-3.92
AKTX Akari Therapeutics Plc Adr	1.30	40.37M	0	0	0	0.00
REGN Regeneron Pharmaceuticals Inc	605.39	64.44B	14.09B	4.50B	2.96B	39.28
VRNA Verona Pharma Plc Adr	77.49	6.19B	0	-153.72M	-103.81M	-2.00

Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-03-23	Resumed	Piper Sandler	Neutral
Jun-09-22	Downgrade	Citigroup	Buy → Neutral
Jun-08-22	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jun-08-22	Downgrade	Piper Sandler	Overweight → Neutral
Mar-23-22	Initiated	B. Riley Securities	Neutral
Nov-09-20	Downgrade	JP Morgan	Overweight → Neutral
Nov-15-19	Resumed	Cantor Fitzgerald	Overweight
Sep-26-19	Resumed	JP Morgan	Overweight
Mar-01-19	Reiterated	Cantor Fitzgerald	Overweight
Aug-27-18	Initiated	Citigroup	Buy
May-02-18	Reiterated	Cantor Fitzgerald	Overweight
Dec-21-17	Resumed	Piper Jaffray	Overweight
Dec-15-17	Initiated	Cantor Fitzgerald	Overweight
Nov-06-17	Resumed	H.C. Wainwright	Buy
Mar-09-17	Reiterated	H.C. Wainwright	Buy
Aug-31-16	Reiterated	H.C. Wainwright	Buy
Aug-30-16	Reiterated	Piper Jaffray	Overweight
Jul-13-16	Initiated	H.C. Wainwright	Buy
Jun-13-16	Initiated	Piper Jaffray	Overweight
Apr-22-16	Upgrade	JP Morgan	Neutral → Overweight
Apr-08-13	Reiterated	Stifel	Buy
Nov-29-12	Initiated	UBS	Neutral
Nov-06-12	Reiterated	Oppenheimer	Outperform
Mar-26-12	Initiated	Canaccord Genuity	Hold
Dec-10-10	Downgrade	MP Advisors	Outperform → Market Perform

View All

Rigel Pharmaceuticals Stock (RIGL) Latest News

09:40 AM

Is Rigel Pharmaceuticals (RIGL) Stock Undervalued Right Now? - Yahoo Finance

09:40 AM

May 28, 2025

Rigel to Present at the Jefferies Global Healthcare Conference - Kilgore News Herald

May 28, 2025

Director Lapointe Anthony Gregg was granted 2,500 shares, increasing direct ownership by 25% to 12,500 units (SEC Form 4) - Quantisnow

May 28, 2025

Director Hannah Alison L. was granted 2,500 shares, increasing direct ownership by 31% to 10,625 units (SEC Form 4) - Quantisnow

May 28, 2025

Wall Street Analysts See a 71.97% Upside in Rigel (RIGL): Can the Stock Really Move This High? - Yahoo Finance

May 28, 2025

Rigel to Present at the Jefferies Global Healthcare Conference | - GuruFocus

May 28, 2025

May 27, 2025

(RIGL) Proactive Strategies - news.stocktradersdaily.com

May 27, 2025

May 26, 2025

Rigel Pharmaceuticals’ SWOT analysis: stock performance and pipeline potential By Investing.com - Investing.com India

May 26, 2025

Rigel Pharmaceuticals’ SWOT analysis: stock performance and pipeline potential - Investing.com

May 26, 2025

May 23, 2025

Rigel Pharmaceuticals Approves Equity Plan Amendment - TipRanks

May 23, 2025

May 22, 2025

Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress | RIGL Stock News - GuruFocus

May 22, 2025

Rigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 Congress - PR Newswire

May 22, 2025

May 18, 2025

17,123 Shares in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Acquired by Dimensional Fund Advisors LP - Defense World

May 18, 2025

May 16, 2025

(RIGL) Investment Analysis - news.stocktradersdaily.com

May 16, 2025

May 15, 2025

Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) CEO Compensation Looks Acceptable To Us And Here's Why - simplywall.st

May 15, 2025

May 14, 2025

Here's Why Rigel (RIGL) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance

May 14, 2025

May 13, 2025

Is Rigel Pharmaceuticals (RIGL) a Great Value Stock Right Now? - Yahoo Finance

May 13, 2025

May 11, 2025

Wall Street Analysts Think Rigel (RIGL) Could Surge 82.3%: Read This Before Placing a Bet - MSN

May 11, 2025

Upgrade: Analysts Just Made A Captivating Increase To Their Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Forecasts - Yahoo Finance

May 11, 2025

Wells Fargo & Company MN Buys 2,648 Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

May 11, 2025

MetLife Investment Management LLC Acquires 2,014 Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

May 09, 2025

Rigel Pharmaceuticals, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - simplywall.st

May 09, 2025

Rigel pharmaceuticals targets $200M-$210M revenue in 2025 with strong Q1 performance - MSN

May 09, 2025

Rigel Pharmaceuticals, Inc. Just Recorded A 370% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance

May 09, 2025

HC Wainwright Issues Positive Outlook for RIGL Earnings - Defense World

May 09, 2025

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2025 Earnings Call Transcript - Insider Monkey

May 09, 2025

May 08, 2025

Rigel Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 08, 2025

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Given Average Rating of “Hold” by Analysts - Defense World

May 08, 2025

May 07, 2025

Rigel Pharmaceuticals Reports Strong Growth and Strategic Advances - TipRanks

May 07, 2025

Rigel Pharmaceuticals: Q1 Earnings Showcase Growing Momentum (NASDAQ:RIGL) - Seeking Alpha

May 07, 2025